We are live on ! Find out more
GDNRW

Gardiner Healthcare Acquisitions Corp. Warrant
GDNRW

Delisted

GDNRW was delisted on the 15th of December, 2023.

0 hedge funds and large institutions have $0 invested in Gardiner Healthcare Acquisitions Corp. Warrant in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 260 (-26)

100% less capital invested

Capital invested by funds: $4.04M → $0 (-$4.04M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 26

Holders
Holders Change
-26
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
26
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
-$3 -111 Closed

GDNRW Hedge Fund Activity: Q4 2023 in Review

0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Gardiner Healthcare Acquisitions Corp. Warrant (GDNRW) for Q4 2023, worth a combined $0 — down 100% from $4.04M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of GDNRW and 0 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Boothbay Fund Management, exiting entirely with an estimated $3.8M sold.

  • 0 institutional investors held Gardiner Healthcare Acquisitions Corp. Warrant (GDNRW) as of Q4 2023, down from 26 in Q3 2023.
  • Funds reported $0 of Gardiner Healthcare Acquisitions Corp. Warrant stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Gardiner Healthcare Acquisitions Corp. Warrant positions in Q4 2023 and 26 closed out, a net change of -26 holders.
  • The largest Gardiner Healthcare Acquisitions Corp. Warrant seller in Q4 2023 was Boothbay Fund Management, an estimated $3.8M sold.

Based on aggregated 13F filings for Q4 2023.